Literature DB >> 11113717

Reduction of hospital days by biventricular pacing.

F Braunschweig1, C Linde, F Gadler, L Rydén.   

Abstract

The health care costs for heart failure are substantial. Studies indicate that hospital treatment constitutes 65-75% of these. The aim of this study was to assess total and heart failure related hospital days as well as safety and efficacy of biventricular pacing in 16 patients with severe heart failure and delayed intraventricular conduction (QRS duration >150 ms). They were implanted with a biventricular pacemaker and followed by NYHA class, 6-min walk test and quality of life for a mean of 291+/-76 days. Total number of hospital days and the need for hospitalisations were monitored. Thirteen responders improved by at least one functional class. After 6 months of pacing the 6-min walk test improved from 375+/-83 m to 437+/-73 m (P<0.001) and Minnesota Living with Heart Failure quality of life score from 41+/-19 to 24+/-17 (P<0.001) compared to baseline. The need for hospital care decreased significantly after biventricular pacing. The total number of hospital days in all patients was 253 the year before compared to 45 the year after biventricular pacing (P<0.01). For heart failure related hospital days the corresponding figures were 183 and 39 days, respectively (P<0.01). Biventricular pacing improved 13/16 patients with severe heart failure and wide QRS complexes in this open study. The improvement resulted in a reduced need for hospital care.

Entities:  

Mesh:

Year:  2000        PMID: 11113717     DOI: 10.1016/s1388-9842(00)00113-6

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  13 in total

Review 1.  Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure.

Authors:  Cecilia Linde
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Early and late QRS morphology and width in biventricular pacing: relationship to lead site and electrical remodeling.

Authors:  Renato Ricci; Carlo Pignalberi; Gerardo Ansalone; Enzo Jannone; Maria Vittoria Vaccaro; Alessandra Denaro; Sergio Cavaglià; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2002-07       Impact factor: 1.900

Review 3.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  New information about resynchronisation.

Authors:  N M van Hemel
Journal:  Neth Heart J       Date:  2003-11       Impact factor: 2.380

5.  Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival.

Authors:  Lothar Faber; Marios Vlachojannis; Olaf Oldenburg; Detlef Hering; Nicola Bogunovic; Dieter Horstkotte; Barbara Lamp
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-01       Impact factor: 2.357

6.  Echocardiography-based optimization of cardiac resynchronization therapy in patients with congestive heart failure and conduction disorders.

Authors:  L Faber
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006

Review 7.  Strategies for pacemaker programming in acute heart failure.

Authors:  Marc K Lahiri; Justin T Mao; Claudio D Schuger
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

Review 8.  Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses.

Authors:  Olatz Garin; Montse Ferrer; Angels Pont; Montserrat Rué; Anna Kotzeva; Ingela Wiklund; Eric Van Ganse; Jordi Alonso
Journal:  Qual Life Res       Date:  2008-12-04       Impact factor: 4.147

9.  Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-09-01

10.  Cardiac resynchronization therapy in congestive heart failure: The state of the art and future perspectives.

Authors:  Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.